Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing NaN - NaN of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Tucson, Arizona
  • +147 more
Jan 24, 2023

Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

Recruiting
  • Carcinoma, Renal Cell
  • Chandler, Arizona
  • +176 more
Jan 19, 2023

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
Has Results
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Birmingham, Alabama
  • +229 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

Recruiting
  • Carcinoma, Renal Cell
  • New York, New York
    Columbia University Medical Center
May 6, 2022

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Huntsville, Alabama
  • +226 more
Apr 19, 2021

Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology, Renal Cell Carcinoma With Clear Cell Histology Trial in

Completed
  • Carcinoma, Renal Cell
  • +3 more
  • Ann Arbor, Michigan
  • +8 more
Dec 16, 2020

Carcinoma, Renal Cell Trial in New York (TroVax, Interleukin-2)

Completed
  • Carcinoma, Renal Cell
  • TroVax
  • Interleukin-2
  • New York, New York
    Columbia Presbyterian Medical Center
Oct 8, 2020

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +6 more
  • Duarte, California
  • +41 more
Mar 4, 2020

Carcinoma, Renal Cell Trial in United Kingdom, United States (Pazopanib, MK-3475)

Completed
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +5 more
Feb 28, 2020

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of varlilumab and sunitinib)

Terminated
  • Carcinoma, Renal Cell
  • +8 more
  • Combination of varlilumab and sunitinib
  • Birmingham, Alabama
  • +8 more
Jul 24, 2018

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

Terminated
  • Carcinoma, Renal Cell
  • +13 more
  • Combination of Varlilumab and Atezolizumab
  • San Francisco, California
  • +3 more
Apr 26, 2018

Carcinoma, Renal Cell Trial in Worldwide (GW786034, Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Duarte, California
  • +44 more
Feb 23, 2017

Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)

Completed
  • Carcinoma, Renal Cell
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +8 more
Dec 17, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Tucson, Arizona
  • +120 more
Jan 8, 2014

Carcinoma, Renal Cell, Kidney Tumors, Kidney Diseases Trial in Baltimore, New York (AGS-16M18)

Terminated
  • Carcinoma, Renal Cell
  • +2 more
  • AGS-16M18
  • Baltimore, Maryland
  • +1 more
Feb 26, 2013

Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Interferon Alfa
  • +2 more
  • Little Rock, Arkansas
  • +153 more
Sep 24, 2012

Update 5-Year Survival Of Subjects Who Participated In Axitinib

Completed
Has Results
  • Carcinoma, Renal Cell
  • axitinib: observational study
  • San Francisco, California
  • +7 more
Apr 18, 2012

Carcinoma, Renal Cell Trial in Worldwide (Sutent)

Approved for marketing
  • Carcinoma, Renal Cell
  • Scottsdale, Arizona
  • +273 more
Mar 8, 2012

Carcinoma, Renal Cell Trial in United States (Sunitinib Malate Continuous Daily Dosing, Sunitinib Malate Schedule 4/2)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sunitinib Malate Continuous Daily Dosing
  • Sunitinib Malate Schedule 4/2
  • Hot Springs, Arkansas
  • +158 more
Aug 3, 2011